Occupe actuellement des postes chez Syndax Pharmaceuticals Inc, Arvinas Inc and NextCure Inc
Position | Company | Period |
---|---|---|
Chief Executive Officer, Director | Syndax Pharmaceuticals Inc | 1 juillet 2015 - |
Independent Director | Arvinas Inc | 1 juin 2018 - |
Independent Director | NextCure Inc | 1 avril 2019 - |
Executive Vice President - Global Medicines Development | AstraZeneca PLC | 1 janvier 2013 - 15 septembre 2015 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-08-10 | 2023-08-09 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Vente |
52 855
-74.8%
18,27965 402 USD |
52 855 -74.8% | 18,27 | 965 402 USD | |
2023-06-09 | 2023-06-09 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Vente |
28 273
-61.3%
21,18598 797 USD |
28 273 -61.3% | 21,18 | 598 797 USD | |
2023-06-09 | 2023-06-09 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Vente |
24 582
-34.8%
21,18520 625 USD |
24 582 -34.8% | 21,18 | 520 625 USD | |
2023-05-10 | 2023-05-09 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Vente |
52 855
-74.8%
21,411 131 478 USD |
52 855 -74.8% | 21,41 | 1 131 478 USD | |
2023-04-12 | 2023-04-10 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Vente |
52 855
-74.8%
19,531 032 237 USD |
52 855 -74.8% | 19,53 | 1 032 237 USD | |
2023-03-14 | 2023-03-13 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
52 854
-74.8%
22,531 190 674 USD |
52 854 -74.8% | 22,53 | 1 190 674 USD | |
2023-02-08 | 2023-02-06 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
52 854
-74.8%
26,831 417 909 USD |
52 854 -74.8% | 26,83 | 1 417 909 USD | |
2022-09-21 | 2022-09-20 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
59 649
-77.0%
23,251 387 012 USD |
59 649 -77.0% | 23,25 | 1 387 012 USD | |
2022-09-21 | 2022-09-19 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
114 339
-86.5%
23,032 633 044 USD |
114 339 -86.5% | 23,03 | 2 633 044 USD | |
2022-09-16 | 2022-09-16 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
53 034
-74.8%
23,221 231 423 USD |
53 034 -74.8% | 23,22 | 1 231 423 USD | |
2022-09-16 | 2022-09-16 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
71 966
-80.1%
23,221 671 015 USD |
71 966 -80.1% | 23,22 | 1 671 015 USD | |
2022-09-16 | 2022-09-15 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
66 775
-78.9%
24,201 616 035 USD |
66 775 -78.9% | 24,20 | 1 616 035 USD | |
2022-09-16 | 2022-09-14 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
87 645
-83.1%
23,802 085 855 USD |
87 645 -83.1% | 23,80 | 2 085 855 USD | |
2022-07-05 | 2022-07-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
62 292
-77.7%
19,001 183 430 USD |
62 292 -77.7% | 19,00 | 1 183 430 USD | |
2022-04-18 | 2022-04-14 |
Arvinas Inc
(ARVN)
|
VP Vente planifiée |
10 754
-35.0%
67,03720 888 USD |
10 754 -35.0% | 67,03 | 720 888 USD | |
2022-04-18 | 2022-04-14 |
Arvinas Inc
(ARVN)
|
VP Vente planifiée |
7 104
-18.8%
66,07469 356 USD |
7 104 -18.8% | 66,07 | 469 356 USD | |
2022-04-18 | 2022-04-14 |
Arvinas Inc
(ARVN)
|
VP Vente planifiée |
3 102
-7.6%
65,24202 372 USD |
3 102 -7.6% | 65,24 | 202 372 USD | |
2022-04-05 | 2022-04-04 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
3 128
-14.9%
18,2957 220 USD |
3 128 -14.9% | 18,29 | 57 220 USD | |
2022-04-05 | 2022-04-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
70 545
-79.8%
17,461 231 568 USD |
70 545 -79.8% | 17,46 | 1 231 568 USD | |
2022-04-05 | 2022-04-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
24 500
-57.9%
17,44427 314 USD |
24 500 -57.9% | 17,44 | 427 314 USD | |
2022-04-05 | 2022-04-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
6 000
-12.4%
17,44104 633 USD |
6 000 -12.4% | 17,44 | 104 633 USD | |
2022-01-19 | 2022-01-14 |
Arvinas Inc
(ARVN)
|
VP Vente planifiée |
2 108
-7.8%
67,69142 696 USD |
2 108 -7.8% | 67,69 | 142 696 USD | |
2022-01-19 | 2022-01-14 |
Arvinas Inc
(ARVN)
|
VP Vente planifiée |
5 100
-16.0%
67,28343 144 USD |
5 100 -16.0% | 67,28 | 343 144 USD | |
2022-01-19 | 2022-01-14 |
Arvinas Inc
(ARVN)
|
VP Vente planifiée |
3 833
-10.7%
65,24250 071 USD |
3 833 -10.7% | 65,24 | 250 071 USD | |
2022-01-19 | 2022-01-14 |
Arvinas Inc
(ARVN)
|
VP Vente planifiée |
9 919
-21.7%
64,33638 109 USD |
9 919 -21.7% | 64,33 | 638 109 USD | |
2021-12-20 | 2021-12-17 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
35 156
-42.1%
20,00703 120 USD |
35 156 -42.1% | 20,00 | 703 120 USD | |
2021-02-17 | 2021-02-17 |
Codiak BioSciences, Inc.
(CDAK)
|
A Achat |
4 761
+inf%
21,0099 981 USD |
4 761 +inf% | 21,00 | 99 981 USD | |
2021-02-10 | 2021-02-08 |
Syndax Pharmaceuticals Inc
(SNDX)
|
VP Vente planifiée |
35 156
-42.1%
20,55722 403 USD |
35 156 -42.1% | 20,55 | 722 403 USD | |
2020-11-12 | 2020-11-10 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Vente |
17 466
-27.3%
20,06350 312 USD |
17 466 -27.3% | 20,06 | 350 312 USD | |
2020-11-12 | 2020-11-09 |
Syndax Pharmaceuticals Inc
(SNDX)
|
V Vente |
62 938
-57.5%
20,041 261 265 USD |
62 938 -57.5% | 20,04 | 1 261 265 USD | |
2020-06-25 | 2020-06-23 |
Repare Therapeutics Inc
(RPTX)
|
A Achat |
4 800
+inf%
20,0096 000 USD |
4 800 +inf% | 20,00 | 96 000 USD | |
2020-03-25 | 2020-03-24 |
Arvinas Inc
(ARVN)
|
A Achat |
2 500
+9.3%
38,1895 450 USD |
2 500 +9.3% | 38,18 | 95 450 USD | |
2020-02-05 | 2020-02-04 |
Syndax Pharmaceuticals Inc
(SNDX)
|
A Achat |
12 500
+39.8%
8,00100 000 USD |
12 500 +39.8% | 8,00 | 100 000 USD | |
2019-10-11 | 2019-10-10 |
Syndax Pharmaceuticals Inc
(SNDX)
|
A Achat |
11 000
+53.9%
5,4059 400 USD |
11 000 +53.9% | 5,40 | 59 400 USD | |
2019-05-13 | 2019-05-13 |
Syndax Pharmaceuticals Inc
(SNDX)
|
A Achat |
7 200
+54.5%
7,2952 517 USD |
7 200 +54.5% | 7,29 | 52 517 USD | |
2019-05-13 | 2019-05-09 |
Syndax Pharmaceuticals Inc
(SNDX)
|
A Achat |
13 200
+inf%
7,5699 726 USD |
13 200 +inf% | 7,56 | 99 726 USD |